Back to DE D. E. Shaw & Co., Inc.

ARCTARCT
17 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in ARCTURUS THERAPEUTICS HLDGS

D. E. Shaw & Co., Inc. holds 392,358 shares of ARCT (ARCTURUS THERAPEUTICS HLDGS), worth $2.6M as of 2026-Q2. The position was increased (+55.7% shares). ARCT represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$2.6M

Current Shares

392,358

Total Value Change

+$2.4M

Total Shares Change

+386,484

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
392,358
+55.7%
$2.6M0.0%$6.72
37
2026-Q1
Increased
252,034
+157.6%
$1.9M0.0%$7.91
42
2025-Q4
Increased
97,823
+62.5%
$599,6550.0%$6.19
35
2025-Q3
Increased
60,213
+476.9%
$1.1M0.0%$18.78
41
2025-Q2
New
10,437
-
$135,7850.0%$13.33
31
2024-Q2
Exited
0
-100.0%
$00.0%$24.35
0
2024-Q1
Decreased
10,355
-86.0%
$349,6880.0%$33.77
0
2023-Q4
Increased
73,795
+65.3%
$2.3M0.0%$31.53
38
2023-Q3
Decreased
44,629
-56.3%
$1.1M0.0%$25.55
0
2023-Q2
New
102,087
-
$2.9M0.0%$26.58
36
2022-Q1
Exited
0
-100.0%
$00.0%$27.54
0
2021-Q4
Increased
128,363
+34.0%
$4.8M0.0%$38.88
35
2021-Q3
Decreased
95,766
-68.6%
$4.6M0.0%$46.75
0
2021-Q2
Increased
305,090
+281.7%
$10.3M0.0%$34.56
45
2021-Q1
New
79,938
-
$3.3M0.0%$38.75
37
2020-Q3
Exited
0
-100.0%
$00.0%$42.73
0
2020-Q2
New
5,874
-
$275,0000.0%$46.98
32

Other major holders of ARCT: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used